You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 52 No. 10, October 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

{tau} Ubiquitin, and {alpha}B-Crystallin Immunohistochemistry Define the Principal Causes of Degenerative Frontotemporal Dementia

Paul N. Cooper, MA; Matthew Jackson, MB,BS; Graham Lennox, MA; James Lowe, DM; David M. A. Mann, PhD

Arch Neurol. 1995;52(10):1011-1015.


Abstract

Objective
We investigated the use of immunostaining with antibodies to {tau}, ubiquitin, and {alpha}B-crystallin in defining a protocol for the staged neuropathologic examination of brains from patients with a progressive frontotemporal dementia.

Design
Brains obtained from 50 patients dying with the clinical diagnosis of frontotemporal dementia were examined histopathologically to define pathologic distinctions.

Setting
Two university hospital neuropathology departments.

Results
Anti-{tau} immunostaining defined corticobasal degeneration, Alzheimer's disease, and Pick's disease; antiubiquitin defined motor neuron disease with dementia. The remaining brains have frontal lobe degeneration: the use of {alpha}B-crystallin immunostaining, on these, to detect ballooned neurons may help to define two groups of patients, one of which we believe may represent a variant of Pick's disease.

Conclusion
These findings indicate that immunostaining with these antibodies is essential for the evaluation of frontal dementia.



Author Affiliations

Medical From the Division of Molecular Pathology, Department of Pathology, Manchester University Med'u School (Mr Cooper and Dr Mann), and the Department of Pathology, University of Nottingham Medical School, Queens Medical Centre (Drs Jackson and Lowe and Mr Lennox), England.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy
Paviour et al.
Brain 2004;127:2441-2451.
ABSTRACT | FULL TEXT  

{alpha}B-Crystallin-coated MAP microtubule resists nocodazole and calcium-induced disassembly
Fujita et al.
J. Cell Sci. 2004;117:1719-1726.
ABSTRACT | FULL TEXT  

Microtubule-associated tau protein positive neuronal and glial inclusions in ALS
Yang et al.
Neurology 2003;61:1766-1773.
ABSTRACT | FULL TEXT  

Total tau and Phosphorylated tau 181 Levels in the Cerebrospinal Fluid of Patients With Frontotemporal Dementia Due to P301L and G272V tau Mutations
Rosso et al.
Arch Neurol 2003;60:1209-1213.
ABSTRACT | FULL TEXT  

Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study
Rosso et al.
Brain 2003;126:2016-2022.
ABSTRACT | FULL TEXT  

Chromosome 3 linked frontotemporal dementia (FTD-3)
Gydesen et al.
Neurology 2002;59:1585-1594.
ABSTRACT | FULL TEXT  

Elevation of beta -Amyloid Peptide 2-42 in Sporadic and Familial Alzheimer's Disease and Its Generation in PS1 Knockout Cells
Wiltfang et al.
J. Biol. Chem. 2001;276:42645-42657.
ABSTRACT | FULL TEXT  

Cognitive impairment in sporadic ALS: A pathologic continuum underlying a multisystem disorder
Wilson et al.
Neurology 2001;57:651-657.
ABSTRACT | FULL TEXT  

Contribution of Asymmetric Synapse Loss to Lateralizing Clinical Deficits in Frontotemporal Dementias
Lipton et al.
Arch Neurol 2001;58:1233-1239.
ABSTRACT | FULL TEXT  

{alpha}B-Crystallin immunolocalization yields new insights into inclusion body myositis
Banwell and Engel
Neurology 2000;54:1033-1041.
ABSTRACT | FULL TEXT  

Semantic dementia with ubiquitin-positive tau-negative inclusion bodies
Rossor et al.
Brain 2000;123:267-276.
ABSTRACT | FULL TEXT  

Dementia as the most common presentation of cortical-basal ganglionic degeneration
Grimes et al.
Neurology 1999;53:1969-1969.
ABSTRACT | FULL TEXT  

Familial Encephalopathy with Neuroserpin Inclusion Bodies
Davis et al.
Am. J. Pathol. 1999;155:1901-1913.
ABSTRACT | FULL TEXT  

Behavioural disturbance and visual hallucinations in a 78 year old man
Schultz et al.
J. Neurol. Neurosurg. Psychiatry 1998;65:933-938.
FULL TEXT  

Familial dementia lacking specific pathological features presenting with clinical features of corticobasal degeneration
Brown et al.
J. Neurol. Neurosurg. Psychiatry 1998;65:600-603.
ABSTRACT | FULL TEXT  

Pick's Disease, Frontotemporal Dementia, and Pick Complex: Emerging Concepts
Kertesz and Munoz
Arch Neurol 1998;55:302-304.
FULL TEXT  

Frontotemporal Dementia, Pick Disease, and Corticobasal Degeneration: One Entity or 3? 1
Kertesz
Arch Neurol 1997;54:1427-1429.
ABSTRACT  

Brain-Stem Inclusions in Motor Neuron Disease-Type Dementia
Cooper et al.
Arch Neurol 1996;53:836-836.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.